These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21411524)

  • 1. Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.
    Lee SH; Jia S; Zhu Y; Utermark T; Signoretti S; Loda M; Schaffhausen B; Roberts TM
    J Virol; 2011 Jun; 85(11):5581-92. PubMed ID: 21411524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.
    Utermark T; Schmit F; Lee SH; Gao X; Schaffhausen BS; Roberts TM
    J Virol; 2014 Sep; 88(18):10673-9. PubMed ID: 24991009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
    Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
    Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
    Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
    Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
    Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
    Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
    Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
    Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
    Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
    Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE
    Toxicol Pathol; 1998; 26(1):177-82. PubMed ID: 9502400
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.
    Maroulakou IG; Anver M; Garrett L; Green JE
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11236-40. PubMed ID: 7972041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
    Guy CT; Cardiff RD; Muller WJ
    Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
    Andrechek ER; Muller WJ
    Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.